Defiance ETFs »

Regeneron Pharmaceuticals shares owned by Defiance ETFs

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Defiance ETFs from 13F filings

Historical chart of Defiance ETFs investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Defiance ETFs consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Defiance ETFs

Quarter filed Position value Share count Share price at filing
2026-03-31 $274k 355 772.64

More positions owned by Defiance ETFs

Oracle Corporation (ORCL)
Iris Energy (IREN)
Broadcom (AVGO)
Rocket Lab Corp (RKLB)
MicroStrategy Incorporated (MSTR)
Ionq Inc Pipe (IONQ)
Altc Acquisition Corp (OKLO)
Hims & Hers Heal (HIMS)
Super Micro Computer Inc Com Usd0.001 (SMCI)
iShares S&P 500 Index (IVV)
Eli Lilly & Co. (LLY)
Ondas Hldgs (ONDS)
Sofi Technologies (SOFI)
NVIDIA Corporation (NVDA)
Novo Nordisk A/S (NVO)

View all positions for Defiance ETFs

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
Vanguard Capital Management
State Street Corporation
Dodge & Cox
Franklin Resources
Geode Capital Management
FMR
Nuveen
Loomis, Sayles and
Invesco
Vanguard Portfolio Management
Goldman Sachs Group
Capital World Investors
Susquehanna International

View all funds holding Regeneron Pharmaceuticals